icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Thu 25 Jun 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Government websites use the protocol. HTTPS for encryption and security.

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Registered with the Digital Government Authority under number:
20250831619
Suggestions

Recall of batch No. 1407169 of the product: Xeractan 20 mg

القسم

Drugs

violet
drugs

Recall of batch No. 1407169 of the product: Xeractan 20 mg

icon 2026-04-20
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Xeractan 20 mg soft gelatin capsule Isotretinoin 2805257489 1407169 GAP SA PHARMACEUTICAL
التصنيف
ملف
التاريخ
2026-04-16
اسم المستحضر
Xeractan 20 mg soft gelatin capsule
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب

The Saudi Food and Drug Authority (SFDA) has issued a recall of batch No. 1407169 of the product Xeractan 20 mg soft gelatin capsules due to out-of-specification results observed during stability studies, which may impact the product’s quality and safety.

التوصيات

For healthcare professionals: Stop dispensing the batch immediately. Embargo/Quarantine all remaining stock. Affected batch should be returned to the supplier.

For patients,

  1. Consult your healthcare provider prior to discontinuing use of the affected batchor for any health concerns.

  2. Contact the recalling firm or SFDA if you have any questions about the recall.
  3. Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).